Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12759]

Immunotherapy combo halts rare, stage 4 sarcoma in teen

Immunotherapy combo halts rare, stage 4 sarcoma in teen

Novel mechanical mechanism of metastatic cancer cells in substrates of different stiffness revealed

Novel mechanical mechanism of metastatic cancer cells in substrates of different stiffness revealed

FDA grants regular approval to venetoclax in combination for untreated acute myeloid leukaemia in adults unable to receive intensive chemotherapy

FDA grants regular approval to venetoclax in combination for untreated acute myeloid leukaemia in adults unable to...

Neo-adjuvant immunotherapy combination effective for non-metastatic bladder cancer

Neo-adjuvant immunotherapy combination effective for non-metastatic bladder cancer

Circulating tumour DNA may predict clinical outcomes with first-line, but not second-line, immunotherapy for melanoma

Circulating tumour DNA may predict clinical outcomes with first-line, but not second-line, immunotherapy for...

Pancreatic cancer: Subtypes with different aggressiveness discovered

Pancreatic cancer: Subtypes with different aggressiveness discovered

Scientists propose potential method for imaging-guided synergistic cancer therapy

Scientists propose potential method for imaging-guided synergistic cancer therapy

FDA extends approval of pembrolizumab for classical hodgkin lymphoma

FDA extends approval of pembrolizumab for classical hodgkin lymphoma

Pancreatic cancer: Subtypes with different aggressiveness discovered

Pancreatic cancer: Subtypes with different aggressiveness discovered

$Inhibition of HDAC and mTOR may improve outcomes for relapsed/refractory Hodgkin lymphoma$

Inhibition of HDAC and mTOR may improve outcomes for relapsed/refractory Hodgkin lymphoma

More from ecancer